Qing-Hong Qin1, Bai-Sha Huang2, Qi-Xing Tan1, Wei-Ping Yang3, Bin Lian1, Chang-Yuan Wei1. 1. Department of Breast Surgery, Guangxi Medical University Tumor Hospital Nanning, China. 2. Department of Surgery, Guangdong Women and Children's Hospital Guangzhou, China. 3. Department of Ultrasound Diagnosis, Guangxi Medical University Tumor Hospital Nanning, China.
Abstract
BACKGROUND: Iodine 125 ((125)I) seed irradiation is an effective non-surgical treatment for unresectable hepatocellular carcinoma (HCC) patients. However, the safety and tolerability of (125)I seed sequential irradiation therapy remain unclear, there is no unified standard of brachytherapy radiation dose, and further study on the basic radiobiology of continuous rate irradiation is necessary. METHODS: Forty Kunming-mice (KM-mice, China) were injected with suspensions of human hepatocellular carcinoma cells (H22) to create an animal model and mimic (125)I seed implantation. The survival rates of mice, curative effect, pathological impairments including apoptosis and necrosis were investigated. The mice were randomly divided into four groups, A, B, C and D. In group A, 0.78 mCi (125)I seeds were implanted into the tumor focus. In groups B and C, 0.58 mCi and 0.38 mCi (125)I seeds were inserted at the same location, respectively. Group D was a control group, without any treatment. After 28 days of therapy, the survival rates and the tumor size were measured, and pathological impairments was measured by light or electron microscopy. RESULTS: The tumor volume inhibition rate was 68.21% ± 3.21%, 51.38% ± 4.96%, and 35.71% ± 2.79% after 0.78 mCi, 0.58 mCi, and 0.38 mCi (125)I seeds irradiation, respectively. However, radiation-related side effects were also observed in the high-dose group. Pathological results showed that radiation effect was closely associated with radiation dose, as the increase of radiation dose, an increase in apoptosis and necrosis was detected. Significant cellular impairments were noted by pathological analysis under electron microscopy. CONCLUSIONS: Our results demonstrate that the Kunming-mouse is an ideal animal to study (125)I brachytherapy, and the curative effect was closely associated with radiation dose. High-dose of brachytherapy may effectively increase apoptosis and necrosis in liver cells in KM-mice. A dose of 0.58 mCi (125)I radioactive particles may be a safe, effective and minimally invasive therapeutic option for liver cancer.
BACKGROUND:Iodine 125 ((125)I) seed irradiation is an effective non-surgical treatment for unresectable hepatocellular carcinoma (HCC) patients. However, the safety and tolerability of (125)I seed sequential irradiation therapy remain unclear, there is no unified standard of brachytherapy radiation dose, and further study on the basic radiobiology of continuous rate irradiation is necessary. METHODS: Forty Kunming-mice (KM-mice, China) were injected with suspensions of humanhepatocellular carcinoma cells (H22) to create an animal model and mimic (125)I seed implantation. The survival rates of mice, curative effect, pathological impairments including apoptosis and necrosis were investigated. The mice were randomly divided into four groups, A, B, C and D. In group A, 0.78 mCi (125)I seeds were implanted into the tumor focus. In groups B and C, 0.58 mCi and 0.38 mCi (125)I seeds were inserted at the same location, respectively. Group D was a control group, without any treatment. After 28 days of therapy, the survival rates and the tumor size were measured, and pathological impairments was measured by light or electron microscopy. RESULTS: The tumor volume inhibition rate was 68.21% ± 3.21%, 51.38% ± 4.96%, and 35.71% ± 2.79% after 0.78 mCi, 0.58 mCi, and 0.38 mCi (125)I seeds irradiation, respectively. However, radiation-related side effects were also observed in the high-dose group. Pathological results showed that radiation effect was closely associated with radiation dose, as the increase of radiation dose, an increase in apoptosis and necrosis was detected. Significant cellular impairments were noted by pathological analysis under electron microscopy. CONCLUSIONS: Our results demonstrate that the Kunming-mouse is an ideal animal to study (125)I brachytherapy, and the curative effect was closely associated with radiation dose. High-dose of brachytherapy may effectively increase apoptosis and necrosis in liver cells in KM-mice. A dose of 0.58 mCi (125)I radioactive particles may be a safe, effective and minimally invasive therapeutic option for liver cancer.
Authors: J B Halligan; K J Stelzer; R C Rostomily; A M Spence; T W Griffin; M S Berger Journal: Int J Radiat Oncol Biol Phys Date: 1996-06-01 Impact factor: 7.038
Authors: L A Dawson; C J McGinn; D Normolle; R K Ten Haken; S Walker; W Ensminger; T S Lawrence Journal: J Clin Oncol Date: 2000-06 Impact factor: 44.544
Authors: P H Gutin; S A Leibel; W M Wara; A Choucair; V A Levin; T L Philips; P Silver; V Da Silva; M S Edwards; R L Davis Journal: J Neurosurg Date: 1987-12 Impact factor: 5.115
Authors: Heath D Skinner; Hadley J Sharp; Ahmed O Kaseb; Milind M Javle; Jean Nicolas Vauthey; Eddie K Abdalla; Marc E Delclos; Prajnan Das; Christopher H Crane; Sunil Krishnan Journal: Acta Oncol Date: 2011-07-27 Impact factor: 4.089
Authors: Lei Chen; Tao Sun; Xuefeng Kan; Shi Chen; Yanqiao Ren; Yanyan Cao; Liangliang Yan; Bin Liang; Bin Xiong; Chuansheng Zheng Journal: J Int Med Res Date: 2020-10 Impact factor: 1.671